RUNX1 and neoplasm: Previous studies have underscored the pro‐tumoral role of Runx1 not only in macrophages but also in various cell types, including cancer cells.[37, 38] Thus, Ro5‐3335 provides a global inhibition of Runx1 and manifests a more profound anti‐tumor effect compared to macrophage specific inhibition of siRNA.